Discussions

Ask a Question
Back to all

Why is particle size a Critical Quality Attribute (CQA) for mRNA Lipid Nanoparticles (LNPs)?

Particle size and its distribution directly dictate the biodistribution, cellular uptake efficiency, and safety profile of mRNA therapeutics. For instance, size determines how effectively LNPs can extravasate from blood vessels and penetrate target tissues or tumors.

For more: Particle Size Characterization